Educate the Educators II
- Describe important elements of the biology, epidemiology, and natural history of HPV infections and their relationship to the development of precancers and cancers of the lower genital tract including those of the cervix, vagina, vulva, anus and perianal areas;
- Identify the immune response to HPV infection, and the cost of HPV infections to the individual and society;
- Identify the content (genotypes) of available FDA licensed HPV vaccines, and understand important elements of vaccine immunogenicity and efficacy;
- Discuss recommendations for use of the HPV vaccine and the limitations of the effectiveness of HPV vaccines;
- Appropriately counsel patients, parents of patients and clinicians about the use of HPV vaccines;
- Discuss important elements of current U.S. cervical cancer screening guidelines;
- Describe the different types of HPV testing methods currently available and their relative strengths and limitations;
- Discuss the accepted clinical uses of HPV assays in screening, triage and management of HPV-associated conditions for the general population, specific age groups, and populations with unusual risk profiles;
- Interpret consensus screening and management guidelines and the new interim guidance for primary HPV screening and how to apply them in a clinical setting; and
- Apply HPV testing and relevant diagnostic tests to clinical practice in a directed, evidence-based and cost-effective manner.
Continuing Medical Education (CME)
ASCCP is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credit(s)TM
ASCCP designates this live activity for a maximum of 2.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All those who have an opportunity to control content (Faculty, Program Directors, Reviewers, Staff, etc), are required to complete a COI based on the following instructions:
ASCCP members and the general public place great trust in the work of the Society. Real or perceived undisclosed conflicts of interest may jeopardize that trust and ASCCP’s effectiveness. Conflicts of interest also may affect the objectivity of decisions that ASCCP officers and volunteers make. To minimize the potential impact of possible conflicts of interest, the Board of Directors has determined that all participants in ASCCP activities must report all real or potential conflicts prior to the activity being developed and delivered to the learners. All disclosure forms are reviewed by the Course Director of each activity. Course Director disclosure forms are reviewed by ASCCP’s Education Committee. Most conflicts involve financial relationships with commercial interests. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. These may include pharmaceutical companies, device manufacturers or distributors, service companies, or other for-profit entities. Relationships with commercial interests may affect how officers or volunteers view products or services. They may also prompt outsiders to assume bias even when none exists, harming the reputation and effectiveness of the Society. Specific relationships with potential to create conflict of interest can include direct employment, management positions including directors and officers, royalties, consultants or board or advisory board positions, lecture fees paid by an entity (including membership on speakers bureaus or review panels), expert testimony especially to regulatory bodies or in litigation, ownership or beneficial ownership of stock or stock options, research funding, honoraria, gifts including travel or other in-kind payments (e.g., accommodations, sports tickets, appliances, electronic devices, etc.), intellectual property rights received or pending, and participation in sponsored research as a principal investigator. Contracted research funded by a commercial source also creates a potential conflict of interest; this includes research funding by which an employing institution receives a grant and manages funds and the CME provider serves as principal or named investigator on the grant. Investments made through diversified mutual funds or blind trusts in which the participant does not exercise decisional control are excluded. Usually primary employment by a nonprofit or governmental organization does not create potential for conflict, but compensation to employers based on an individual’s work with a for-profit company may create bias that must be reported. Income from commercial entities unrelated to health care does not create a potential for conflict of interest. By disclosing all relationships, participants and the Society allow others to judge the extent to which conflicts may have affected judgments in conscious or unconscious ways. If the potential for any relationship to create conflict of interest appears doubtful, then it should be disclosed.